MAPT and Alzheimer disease: As Tau1 was used in further studies using AD brain tissue, it became clear that the tau proteins in the pathological inclusions were phosphorylated and that removing phosphorylation dramatically increased the reactivity of pathology with Tau1 in disease tissue (Grundke-Iqbal et al., 1986b; Wood et al., 1986).